Concepts (225)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 7 | 2022 | 464 | 2.290 |
Why?
|
| Health Knowledge, Attitudes, Practice | 7 | 2019 | 393 | 1.640 |
Why?
|
| Health Care Costs | 6 | 2019 | 253 | 1.620 |
Why?
|
| Early Detection of Cancer | 7 | 2023 | 510 | 1.600 |
Why?
|
| Skin Neoplasms | 3 | 2023 | 64 | 1.540 |
Why?
|
| Communication | 6 | 2021 | 205 | 1.490 |
Why?
|
| Physician-Patient Relations | 3 | 2019 | 202 | 1.450 |
Why?
|
| Patient Acceptance of Health Care | 7 | 2020 | 397 | 1.360 |
Why?
|
| Vaccination | 6 | 2022 | 664 | 1.290 |
Why?
|
| Health Expenditures | 4 | 2020 | 81 | 1.250 |
Why?
|
| Genomics | 3 | 2021 | 65 | 1.240 |
Why?
|
| Humans | 48 | 2023 | 18058 | 1.240 |
Why?
|
| Medical Oncology | 4 | 2016 | 33 | 1.210 |
Why?
|
| Parents | 7 | 2020 | 308 | 1.100 |
Why?
|
| Mass Screening | 7 | 2023 | 678 | 1.050 |
Why?
|
| Psychometrics | 2 | 2019 | 120 | 1.050 |
Why?
|
| Melanoma | 2 | 2023 | 37 | 1.010 |
Why?
|
| Vaccines | 5 | 2022 | 222 | 0.980 |
Why?
|
| Patient Preference | 2 | 2017 | 49 | 0.930 |
Why?
|
| Professional-Family Relations | 3 | 2020 | 50 | 0.830 |
Why?
|
| Duty to Recontact | 1 | 2021 | 2 | 0.780 |
Why?
|
| Leadership | 2 | 2020 | 42 | 0.780 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 13 | 0.770 |
Why?
|
| Genetic Research | 2 | 2019 | 8 | 0.760 |
Why?
|
| Washington | 6 | 2021 | 384 | 0.760 |
Why?
|
| Physicians | 3 | 2020 | 143 | 0.760 |
Why?
|
| Behavioral Medicine | 1 | 2020 | 4 | 0.760 |
Why?
|
| Cancer Survivors | 2 | 2020 | 88 | 0.710 |
Why?
|
| Workflow | 1 | 2019 | 11 | 0.690 |
Why?
|
| Ethics Committees, Research | 1 | 2019 | 11 | 0.690 |
Why?
|
| Policy | 1 | 2019 | 19 | 0.680 |
Why?
|
| Genetic Testing | 3 | 2022 | 89 | 0.680 |
Why?
|
| Social Determinants of Health | 1 | 2019 | 40 | 0.680 |
Why?
|
| Multicenter Studies as Topic | 1 | 2019 | 81 | 0.670 |
Why?
|
| Health Communication | 2 | 2017 | 17 | 0.670 |
Why?
|
| Adult | 16 | 2023 | 7696 | 0.650 |
Why?
|
| Decision Making | 2 | 2011 | 204 | 0.640 |
Why?
|
| Risk Assessment | 4 | 2019 | 1137 | 0.640 |
Why?
|
| Patient Selection | 4 | 2011 | 194 | 0.640 |
Why?
|
| Sunburn | 1 | 2018 | 7 | 0.630 |
Why?
|
| Health Behavior | 2 | 2018 | 379 | 0.620 |
Why?
|
| Pancreatic Neoplasms | 1 | 2019 | 67 | 0.620 |
Why?
|
| Colorectal Neoplasms | 4 | 2021 | 643 | 0.620 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 177 | 0.610 |
Why?
|
| Papillomavirus Vaccines | 2 | 2017 | 119 | 0.590 |
Why?
|
| Prostatic Neoplasms | 2 | 2011 | 299 | 0.590 |
Why?
|
| Primary Health Care | 3 | 2023 | 843 | 0.590 |
Why?
|
| Papillomavirus Infections | 2 | 2017 | 131 | 0.590 |
Why?
|
| Adolescent | 10 | 2023 | 3714 | 0.580 |
Why?
|
| Ambulatory Care | 1 | 2019 | 274 | 0.580 |
Why?
|
| Point-of-Care Systems | 1 | 2016 | 8 | 0.580 |
Why?
|
| Cancer Care Facilities | 1 | 2016 | 5 | 0.580 |
Why?
|
| Insurance Coverage | 2 | 2019 | 136 | 0.570 |
Why?
|
| Mothers | 1 | 2017 | 110 | 0.550 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 57 | 0.550 |
Why?
|
| Counseling | 1 | 2018 | 199 | 0.550 |
Why?
|
| Disclosure | 1 | 2016 | 19 | 0.540 |
Why?
|
| Surveys and Questionnaires | 7 | 2021 | 1346 | 0.540 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2022 | 407 | 0.530 |
Why?
|
| Value-Based Purchasing | 1 | 2014 | 3 | 0.490 |
Why?
|
| Evidence-Based Medicine | 3 | 2016 | 195 | 0.490 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2014 | 20 | 0.490 |
Why?
|
| Female | 17 | 2021 | 12838 | 0.460 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 227 | 0.460 |
Why?
|
| Male | 16 | 2021 | 10173 | 0.440 |
Why?
|
| Neptune | 1 | 2021 | 1 | 0.400 |
Why?
|
| United States | 9 | 2023 | 4119 | 0.400 |
Why?
|
| Advisory Committees | 3 | 2016 | 111 | 0.390 |
Why?
|
| Quality of Life | 4 | 2022 | 509 | 0.390 |
Why?
|
| Patient Education as Topic | 2 | 2009 | 215 | 0.360 |
Why?
|
| Risk Factors | 6 | 2020 | 3394 | 0.360 |
Why?
|
| Uncertainty | 1 | 2009 | 8 | 0.340 |
Why?
|
| Cost of Illness | 2 | 2020 | 97 | 0.340 |
Why?
|
| Middle Aged | 10 | 2021 | 8073 | 0.340 |
Why?
|
| Vaccination Refusal | 2 | 2019 | 10 | 0.330 |
Why?
|
| Qualitative Research | 2 | 2020 | 267 | 0.330 |
Why?
|
| Family | 2 | 2022 | 119 | 0.330 |
Why?
|
| Physicians, Primary Care | 2 | 2021 | 75 | 0.320 |
Why?
|
| Pharmacogenetics | 1 | 2007 | 16 | 0.300 |
Why?
|
| Incidental Findings | 1 | 2007 | 30 | 0.300 |
Why?
|
| Aged | 8 | 2021 | 6258 | 0.300 |
Why?
|
| Colonoscopy | 2 | 2021 | 265 | 0.300 |
Why?
|
| Preventive Health Services | 3 | 2016 | 164 | 0.280 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 394 | 0.280 |
Why?
|
| Registries | 2 | 2014 | 486 | 0.280 |
Why?
|
| Interviews as Topic | 3 | 2019 | 327 | 0.270 |
Why?
|
| Health Policy | 1 | 2007 | 135 | 0.270 |
Why?
|
| Referral and Consultation | 1 | 2007 | 178 | 0.270 |
Why?
|
| Treatment Outcome | 4 | 2022 | 1259 | 0.270 |
Why?
|
| Physical Examination | 2 | 2023 | 21 | 0.260 |
Why?
|
| Minority Groups | 2 | 2020 | 103 | 0.250 |
Why?
|
| Exercise Therapy | 2 | 2018 | 70 | 0.240 |
Why?
|
| Sensitivity and Specificity | 3 | 2019 | 318 | 0.230 |
Why?
|
| Young Adult | 5 | 2019 | 2479 | 0.230 |
Why?
|
| Veterans Health | 1 | 2023 | 21 | 0.220 |
Why?
|
| Pilot Projects | 2 | 2016 | 235 | 0.220 |
Why?
|
| Infant | 5 | 2020 | 1212 | 0.220 |
Why?
|
| Prevalence | 2 | 2015 | 892 | 0.210 |
Why?
|
| Attitude to Health | 2 | 2018 | 179 | 0.210 |
Why?
|
| Genetic Counseling | 1 | 2022 | 36 | 0.200 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 1309 | 0.200 |
Why?
|
| Burnout, Professional | 1 | 2021 | 16 | 0.200 |
Why?
|
| Smartphone | 1 | 2021 | 11 | 0.190 |
Why?
|
| Models, Economic | 1 | 2020 | 21 | 0.190 |
Why?
|
| Research Personnel | 1 | 2020 | 30 | 0.190 |
Why?
|
| Child | 5 | 2018 | 2519 | 0.180 |
Why?
|
| Medical Overuse | 1 | 2020 | 13 | 0.180 |
Why?
|
| Occult Blood | 1 | 2021 | 159 | 0.180 |
Why?
|
| Telephone | 1 | 2021 | 175 | 0.180 |
Why?
|
| Pancreas | 1 | 2019 | 14 | 0.170 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2019 | 24 | 0.170 |
Why?
|
| Infant, Newborn | 3 | 2019 | 852 | 0.170 |
Why?
|
| Consumer Behavior | 1 | 2019 | 31 | 0.170 |
Why?
|
| Postoperative Complications | 1 | 2019 | 101 | 0.160 |
Why?
|
| Hospitals, Pediatric | 1 | 2019 | 80 | 0.160 |
Why?
|
| Self-Examination | 1 | 2018 | 4 | 0.160 |
Why?
|
| Sunscreening Agents | 1 | 2018 | 7 | 0.160 |
Why?
|
| Skin Pigmentation | 1 | 2018 | 6 | 0.160 |
Why?
|
| Braces | 1 | 2018 | 2 | 0.160 |
Why?
|
| Scoliosis | 1 | 2018 | 3 | 0.160 |
Why?
|
| Preventive Medicine | 1 | 2018 | 25 | 0.150 |
Why?
|
| Precancerous Conditions | 1 | 2018 | 48 | 0.150 |
Why?
|
| Medical History Taking | 1 | 2017 | 35 | 0.150 |
Why?
|
| Social Work | 1 | 1997 | 14 | 0.150 |
Why?
|
| Homeless Persons | 1 | 1997 | 26 | 0.140 |
Why?
|
| Physician's Role | 1 | 2017 | 33 | 0.140 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2016 | 2 | 0.140 |
Why?
|
| Unnecessary Procedures | 1 | 2016 | 24 | 0.140 |
Why?
|
| Housing | 1 | 1997 | 40 | 0.140 |
Why?
|
| Ethnic Groups | 1 | 2020 | 504 | 0.140 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 445 | 0.140 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2016 | 24 | 0.140 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2016 | 55 | 0.130 |
Why?
|
| Dyslipidemias | 1 | 2016 | 63 | 0.130 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 1956 | 0.130 |
Why?
|
| Choice Behavior | 1 | 2015 | 48 | 0.130 |
Why?
|
| Perception | 1 | 2015 | 55 | 0.130 |
Why?
|
| Family Health | 1 | 2015 | 47 | 0.130 |
Why?
|
| Northwestern United States | 1 | 2014 | 47 | 0.120 |
Why?
|
| Health Information Systems | 1 | 2014 | 4 | 0.120 |
Why?
|
| Mass Vaccination | 1 | 2014 | 22 | 0.120 |
Why?
|
| Hospitalization | 1 | 2019 | 813 | 0.120 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 1255 | 0.120 |
Why?
|
| Data Collection | 1 | 2014 | 276 | 0.110 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 595 | 0.110 |
Why?
|
| Internet | 1 | 2014 | 247 | 0.100 |
Why?
|
| Manipulation, Spinal | 1 | 2011 | 3 | 0.100 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 12 | 0.100 |
Why?
|
| Age Factors | 3 | 2021 | 945 | 0.100 |
Why?
|
| Software | 1 | 2021 | 22 | 0.100 |
Why?
|
| Acupuncture Therapy | 1 | 2011 | 34 | 0.100 |
Why?
|
| Low Back Pain | 1 | 2011 | 54 | 0.100 |
Why?
|
| Interview, Psychological | 1 | 2011 | 19 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 3 | 2021 | 324 | 0.100 |
Why?
|
| Chronic Pain | 1 | 2011 | 125 | 0.090 |
Why?
|
| Time Factors | 2 | 2011 | 1114 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 328 | 0.090 |
Why?
|
| Focus Groups | 1 | 2009 | 152 | 0.080 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2014 | 552 | 0.080 |
Why?
|
| Patient Participation | 1 | 2009 | 143 | 0.080 |
Why?
|
| Pharmacokinetics | 1 | 2007 | 1 | 0.080 |
Why?
|
| Biotransformation | 1 | 2007 | 3 | 0.080 |
Why?
|
| Genetic Privacy | 1 | 2007 | 2 | 0.080 |
Why?
|
| Patient-Centered Care | 2 | 2023 | 228 | 0.080 |
Why?
|
| Cholesterol | 2 | 2016 | 112 | 0.070 |
Why?
|
| Genetic Services | 1 | 2005 | 2 | 0.070 |
Why?
|
| Stress, Psychological | 1 | 2007 | 145 | 0.070 |
Why?
|
| Cholesterol, LDL | 2 | 2016 | 124 | 0.070 |
Why?
|
| Electronic Health Records | 1 | 2021 | 734 | 0.070 |
Why?
|
| Biomarkers | 2 | 2016 | 306 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 454 | 0.060 |
Why?
|
| Myocardial Infarction | 2 | 2016 | 251 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2007 | 1164 | 0.060 |
Why?
|
| Mental Disorders | 1 | 2007 | 290 | 0.060 |
Why?
|
| Child, Preschool | 2 | 2020 | 1428 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 2 | 2017 | 264 | 0.060 |
Why?
|
| Stroke | 2 | 2016 | 306 | 0.060 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2023 | 126 | 0.050 |
Why?
|
| Patient Outcome Assessment | 1 | 2022 | 29 | 0.050 |
Why?
|
| Patients | 1 | 2022 | 39 | 0.050 |
Why?
|
| Job Satisfaction | 1 | 2021 | 20 | 0.050 |
Why?
|
| Workplace | 1 | 2021 | 38 | 0.050 |
Why?
|
| Workload | 1 | 2021 | 31 | 0.050 |
Why?
|
| Sigmoidoscopy | 1 | 2021 | 67 | 0.050 |
Why?
|
| Mobile Applications | 1 | 2021 | 14 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 205 | 0.040 |
Why?
|
| Models, Organizational | 1 | 2020 | 69 | 0.040 |
Why?
|
| Evidence-Based Practice | 1 | 2020 | 53 | 0.040 |
Why?
|
| Risk | 1 | 2021 | 552 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2019 | 97 | 0.040 |
Why?
|
| Health Personnel | 1 | 2020 | 122 | 0.040 |
Why?
|
| Inpatients | 1 | 2019 | 79 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 667 | 0.040 |
Why?
|
| Linear Models | 1 | 2018 | 240 | 0.040 |
Why?
|
| Medical Indigency | 1 | 1997 | 5 | 0.040 |
Why?
|
| Social Marketing | 1 | 2017 | 13 | 0.040 |
Why?
|
| Power (Psychology) | 1 | 2016 | 3 | 0.040 |
Why?
|
| Food Services | 1 | 1997 | 15 | 0.040 |
Why?
|
| Organizational Culture | 1 | 2016 | 19 | 0.040 |
Why?
|
| Trust | 1 | 2017 | 32 | 0.040 |
Why?
|
| Disease Progression | 1 | 2018 | 255 | 0.040 |
Why?
|
| Massachusetts | 1 | 1997 | 100 | 0.040 |
Why?
|
| Ezetimibe | 1 | 2016 | 3 | 0.040 |
Why?
|
| Dermatology | 1 | 2016 | 6 | 0.040 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2016 | 7 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2016 | 20 | 0.040 |
Why?
|
| Simvastatin | 1 | 2016 | 11 | 0.040 |
Why?
|
| Observational Studies as Topic | 1 | 2016 | 49 | 0.030 |
Why?
|
| Hypolipidemic Agents | 1 | 2016 | 45 | 0.030 |
Why?
|
| Urban Population | 1 | 1997 | 122 | 0.030 |
Why?
|
| Age Distribution | 1 | 2016 | 257 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2016 | 51 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2023 | 2498 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 705 | 0.030 |
Why?
|
| Mental Health Services | 1 | 1997 | 159 | 0.030 |
Why?
|
| Life Style | 1 | 2016 | 329 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 177 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2018 | 1294 | 0.030 |
Why?
|
| Public Health | 1 | 2014 | 80 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2014 | 89 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2014 | 330 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2011 | 28 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2018 | 2631 | 0.020 |
Why?
|
| Publishing | 1 | 2005 | 8 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2005 | 89 | 0.020 |
Why?
|
Concepts
(225)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(19)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
-->